2024
In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction).
Hill K, Dunham K, Doneski K, Sue K, Thakarar K, Butner J. In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction). Substance Use & Addiction Journal 2024, 29767342241277619. PMID: 39215532, DOI: 10.1177/29767342241277619.Peer-Reviewed Original ResearchDrug offensesDrug useCriminalization of drug useSocial safety netDecriminalization of drugsHarm reduction servicesWell-beingHarm reduction strategiesConsequences of drug useWell-being of peopleNegative consequences of drug useCommunity supervisionAddiction treatment servicesHealth of PWUDCriminal sanctionsSafety netReduction servicesTreatment servicesDecriminalizationAddiction servicesIllicit drugsOffensesNegative consequencesPWUDUnited StatesIn Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Use & Addiction Journal 2024, 45: 328-336. PMID: 38747578, DOI: 10.1177/29767342241252590.Peer-Reviewed Original ResearchPrevention CenterRates of fatal overdoseSubstance Use and AddictionDrop-in serviceEvidence-based strategiesHarm reduction strategiesMultidisciplinary Education and ResearchUnited StatesLifesaving servicesMedical careAdvocacy effortsIncrease accessPosition statementSocial servicesFatal overdoseEducation and ResearchDrug supplyTrained personnelPWUDPolicy changesFederal levelReduction strategiesInternational dataSterile suppliesServices
2023
In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)
Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.Peer-Reviewed Original ResearchHarm reduction strategiesPosition statementSerious adverse eventsImportant harm reduction strategyPublic health practitionersAdverse eventsUnregulated drug supplyFatal overdosesHealthcare providersComposition of drugsHealth consequencesHealth practitionersDrugsDrug supplyInsufficient dataDrug checkingUnited StatesRecognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut
Dowton A, Doernberg M, Heiman E, Barelli P, Golden M, Wang H, Leventhal J, Morford K, Sue K. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal Of Addiction Medicine 2023, 17: 739-741. PMID: 37934550, DOI: 10.1097/adm.0000000000001198.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersDrug useCase report presentsIndex of suspicionInjection drug useDrug supplyCare management strategiesHarm reduction strategiesOverdose presentationsCutaneous manifestationsWithdrawal syndromeClinical complicationsCase reportIntravenous useWound carePatientsTreatment of woundsInfectious diseasesChronic woundsXylazineSkin woundsWoundsMore reportingDiagnosis
2022
Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection
Rosen J, Glick J, Zhang L, Cooper L, Olatunde P, Pelaez D, Rouhani S, Sue K, Park J. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction 2022, 118: 847-854. PMID: 36468191, PMCID: PMC10073256, DOI: 10.1111/add.16103.Peer-Reviewed Original ResearchConceptsThreat of violenceCross-sectional qualitative studyDepth interviewsHarm reduction strategiesPublic spaceOverdose riskDrug useThematic analysisQualitative studyEmergent designSocial environmentRisk environmentNaloxone possessionBaltimore CityInterviewsWWIDReduction strategiesOpioid withdrawalViolenceFatal overdoseStreet interceptXylazine and Overdoses: Trends, Concerns, and Recommendations.
Alexander RS, Canver BR, Sue KL, Morford KL. Xylazine and Overdoses: Trends, Concerns, and Recommendations. American Journal Of Public Health 2022, 112: 1212-1216. PMID: 35830662, PMCID: PMC9342814, DOI: 10.2105/ajph.2022.306881.Peer-Reviewed Original ResearchConceptsIllicit drug supplyDrug supplyNovel treatment strategiesPublic health interventionsPublic health systemHarm reduction strategiesTreatment strategiesOverdose deathsHealth interventionsStriking prevalenceHealth systemXylazineExposure levelsPrevalencePotential riskPotential toxicityOpioidsOverdoses